VERU News and Press, Veru Inc. From 11/23/22

After Veru (NASDAQ: VERU) got a thumbs-down from a nonbinding advisory committee at the Food and Drug Administration (FDA) on Nov. 9 regarding its drug sabizabulin for the treatment of severe COVID-19, shares of the company fell by more than 60%, and recovery is nowhere in sight. ...

Veru (NASDAQ: VERU) , a biopharmaceutical company that looks for novel cancer therapies, particularly in breast cancer or prostate cancer, saw its shares drop 10.33% on Monday. The stock closed on Friday at $6, then opened on Monday at $5.89. It fell to a low of $5.33 before clo...

San Francisco, California--(Newsfile Corp. - November 17, 2022) - Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now . The firm is investigating possible securities law violations Visit: www.hbsslaw.com/investor-fraud/VERU Conta...

Summary Veru's potential COVID therapy for hospitalized patients received a thumbs down from the FDA's Advisory Committee. Eight panel members voted against handing the drug an emergency use authorization, with five voting in favor. After the news was announced Veru stock slip...

The stock of Veru (NASDAQ: VERU) did not have a good week. As of midafternoon Friday, the share price was down by more than 35% week to date, according to data compiled by S&P Global Market Intelligence . It seems the company's experimental COVID-19 drug has a dim future at ...

Shares of the small-cap biopharma Veru (NASDAQ: VERU) are under heavy pressure today. The drugmaker's shares are down by a noteworthy 52% on sky-high volume as of 11:56 a.m. ET Thursday morning. Veru's shares are taking a big haircut this morning in response to a negative ad...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Jonathan Weiss / Shutterstock.com Oracle (NYSE: ORCL ) layoffs are worth checking out on Thursday as investors keep track of companies cutting employees. Just like many other tech companies, Oracle ha...

Boston, Massachusetts--(Newsfile Corp. - November 10, 2022) - Block & Leviton is investigating Veru Corp. (NASDAQ: VERU) for potential securities law violations. Investors who have lost money in their Veru investment should contact the firm to learn more about how they might recover thos...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When a regulator hits the brakes on a drug’s advancement, small businesses can buckle under the pressure. This seems to be happening with Veru (NASDAQ: VERU ) today as the Food and Drug Administration (FDA) deni...

Veru Inc. ( NASDAQ: VERU ), a biopharma targeting cancer, shed ~65% of its value on Thursday pre-market after a group of independent experts at the FDA voted against granting the emergency use authorization (EUA) for its oral COVID-19 therapy sabizabulin. The sello...